As one of the women responsible for designing the Oxford-AstraZeneca vaccine, Professor Sarah Gilbert has received a lot of attention over the last two years. From being made a Dame to receiving a ...
Just 48,000 of those were AstraZeneca. The vaccine has also been sidelined in the EU and was never approved in the United States. So how did we end up here? I've been talking to scientists ...
Oxford vaccine: How did they make it so quickly? Scientists find trigger of rare blood clots with AstraZeneca jab AstraZeneca faces legal challenge over Covid vaccine Widow sues AstraZeneca after ...
AstraZeneca has admitted for the first time in court documents that its Covid vaccine can cause a rare side effect, in an apparent about-turn that could pave the way for a multi-million pound ...
Scientists in the UK are ... early results by late May or early June. AstraZeneca also announced a separate combination trial between for its vaccine and Russia's Sputnik V.
Two vaccines were studied: those made by Pfizer and AstraZeneca. So, is mix and match an option? The trial’s results are preliminary, having yet to be reviewed by other scientists, but the answer ...
Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...
Scientists have long leveraged this ability ... For Gilbert and Salman, work hasn’t stopped with the rollout of the Oxford/AstraZeneca vaccine. “We’re really busy,” says Gilbert, adding ...
In addition to the AstraZeneca–Oxford and Moderna ... the initial release of viral genome data by Chinese scientists guided subsequent vaccine design, and vigorous viral surveillance in the ...
Stories on the discovery of vital fluid-transport systems in the human body are among the winners of the 2024 AAAS Kavli Science Journalism Awards. Winning journalists also did immersive stories on ...
But scientists are still trying to figure ... In a study of 11 people who developed clots after receiving AstraZeneca's vaccine, they all tested positive for antibodies against that same platelet.
Citigroup CEO Jane Fraser says there is a lot of pent-up demand for M&A during an interview with Sonali Basak on Bloomberg ...